Adhesion Barrier Market by Product (Regenerated Cellulose, Hyaluronic Acid, Polyethylene Glycol, Fibrin, Collagen & Protein), Type (Film, Gel, Liquid), Application (Abdominal, Orthopedic, Cardiovascular, Gynecological Surgery) - Global Forecast to 2025
The global adhesion barrier market size is projected to reach USD 769 million by 2025, at a CAGR of 7.8%. The increasing volume of surgeries and sports-related injuries, rising geriatric population, and the increasing awareness about adhesion formation and adhesion-related diseases are the major factors driving the growth of this market. However, currently, due to the COVID-19 pandemic, this market is witnessing a slight dip in its growth rate as a result of the decrease in the number of surgical procedures performed to safeguard patients. But the normalization of the global economy will slowly increase the surgical procedures kept on hold. This will, in turn, lead to a growth in the demand for biosurgery products from the last quarter of 2020 across North America and Europe, and from the first quarter of 2021 across the rest of the world.
Reluctance towards the usage of adhesion barriers amongst surgeons and product recalls is expected to restrain the growth of this market during the forecast period.
To know about the assumptions considered for the study, Request for Free Sample Report
Adhesion Barrier Market Dynamics
Drivers: Increase in the volume of surgeries and sports-related injuries
Post-surgical adhesions lead to different complications in different surgeries, such as severe abdominal pain in the case of abdominal surgeries, infertility in women after gynaecological surgeries, and physical impairment of patients after neurological surgeries. Considering the severe effects of post-surgery adhesions in patients, the importance of products such as adhesion barriers is increasing in the market. Also, considering the growth in the number of surgeries performed globally, the importance of these products will be more pronounced in the coming years.
Restraint: Reluctance of surgeons to use adhesion barriers
Even though surgeons are aware of these risks, they are reluctant to use adhesion barriers owing to the lack of/limited reliable clinical evidence supporting the safety and efficacy of commercialized adhesion barrier products. Also, due to issues regarding the safety and efficacy of adhesion barriers, companies find it difficult to get marketing approvals for their products. Also, over the last few years, the market has witnessed the discontinuation of approved adhesion barrier products due to poor clinical outcomes.
Opportunities: Untapped emerging markets
The penetration of adhesion barriers is very low in the Asia Pacific, Latin America, and the Middle East and Africa. In the coming years, countries such as South Korea, China, India, Mexico, and Brazil are expected to offer significant growth opportunities for players operating in the adhesion barriers market as these countries have a large patient base for target indications, such as cardiovascular, orthopedic, general/abdominal, and gynecological disorders. The number of surgical procedures, such as cardiac surgeries, general and abdominal surgeries, urological surgeries, gynecological surgeries, and orthopedic surgeries, is also on the rise in countries across emerging markets. Also, the number of surgeries being performed across APAC and the Middle East is increasing, owing to an increased influx of medical tourists in these regions. The increasing disease burden and volume of surgical procedures performed in emerging markets are expected to create growth opportunities for key players operating in the adhesion barriers market.
Challenges: Stringent regulations leading to limited technological innovations
The development of new adhesion barriers requires significant investments, and new products generally take more than 78 years to gain marketing approval. The cost and time required for a product to enter the clinical trial stage and then clear the clinical trials are very high, with minimum chances of the product gaining approval. Also, the possibility of obtaining clinically significant data showing efficacy and safety has been low for most adhesion barriers, barring a few. Hence, despite huge investments in R&D, the risk of failure is very high in the case of adhesion barriers. This is a major factor limiting the development of novel adhesion barriers in the market.
The synthetic adhesion barrier product segment is expected to grow the fastest during the forecast period.
Synthetic adhesion barriers are the most widely used post-surgical adhesion prevention products; this segment accounted for the largest share of the adhesion barriers market in 2019 and is growing at the fastest rate. Owing to their resorbable properties, synthetic barriers help eliminate the need for a second surgery for implant removal. They are more cost-effective than natural adhesion barriers.
By formulation, the film-based formulations accounted for the largest share of the adhesion barrier market in 2019
Depending on formulation type, the adhesion barriers market is segmented into film formulations, gel formulations, and liquid formulations. In 2019, film formulations dominated this market. The large share of this segment can be attributed to the availability of a wide range of film-form adhesion barriers and the strong clinical evidence supporting the safety and efficacy of these adhesion barriers. These factors, coupled with their ease of use, have increased the adoption of film-form adhesion barriers among surgeons as compared to gel- and liquid-form adhesion barriers.
APAC will grow at the fastest rate during the forecast period.
The adhesion barrier market, by region, is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific is the most lucrative healthcare market, owing to its large population and growing healthcare sector. With a large and growing population in countries like China and India, the overall disease prevalence is also rising at an alarming rate in this region. The rapidly growing geriatric population, epidemiological shift from infectious to chronic diseases, increased life expectancy, the expansion of private-sector hospitals in rural areas, and the increased demand for surgical interventions are driving the demand for better healthcare facilities, medical devices, and technologies in the region.
To know about the assumptions considered for the study, download the pdf brochure
Key Market Players
Baxter International (US), Johnson & Johnson (J&J) (US), and Becton, Dickinson and Company (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll (Ireland), Betatech Medical (Turkey), CorMatrix Cardiovascular, Inc. (US), Terumo Corporation (Japan), BiosCompass (US), W.L.Gore & Associates (US), and Allosource (US).
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
:
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market size available for years |
20182025 |
|
Base year considered |
2019 |
|
Forecast period |
20202025 |
|
Forecast unit |
Value (USD Million) |
|
Segments covered |
Type of Product, formulation, and application |
|
Geographies covered |
|
|
Companies Covered |
Johnson & Johnson (US), Baxter International (US), Becton, Dickinson, and Company (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll Holdings (Ireland), Betatech Medical (Turkey), CorMatrix Cardiovascular, Inc. (US), Terumo Corporation (Japan), BiosCompass (US), WL Gore & Associates (US), Allosource (US) (Total 15 companies and 5 other companies undergoing clinical trials) |
The research report categorizes the adhesion barrier market into the following segments and subsegments:
By Type
- Synthetic Adhesion Barriers
- Hyaluronic Acid
- Regenerated Cellulose
- Polyethylene Glycol
- Other Synthetic Adhesion Barrers
- Natural Adhesion Barriers
- Collagen & Protein
- Fibrin
By Delivery Mode
- Film Formulations
- Gel Formulations
- Liquid Formulations
By Application
- Gynecological Surgeries
- General/Abdominal Surgeries
- Orthopedic Surgeries
- Cardiovascular Surgeries
- Neurological Surgeries
- Urological Surgeries
- Reconstructive Surgeries
- Other Surgeries**
- **Other surgeries include ear, nose, throat, and burn surgerie
By Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe (RoE)
- Asia Pacific
- Japan
- China
- India
- Rest of Asia Pacific (RoAPAC)
- Latin America
- Brazil
- Mexico
- Rest of Latin America (RoLATAM)
- Middle East
- Africa
Recent Developments
- In December 2019, Baxters decision to acquire the Seprafilm adhesion barrier and related assets from Sanofi, which is one of the top players in this market, complemented its hemostat and sealant portfolio and strengthened the companys presence in this market..
- In October 2018, FzioMed launched the Oxiplex/IU Intrauterine Adhesion Barrier gel.
- In December 2017, BD acquired C.R.Bard;this acquisition enabled the companies to combine their resources and position themselves as leaders in the global medical device technology industry, including the adhesion barriers market
Frequently Asked Questions (FAQ):
What are the products considered as out of scope for this study?
The study excludes the use of other procedures and products for preventing adhesions, such as surgical procedures, antiadhesive agents, drugs, and physical therapies.Additionally, the study also excludes the market for products that have not been approved for adhesion prevention and are used off-label.
How was the final market size arrived at for the adhesion barrier market?
The total size of the adhesion barrier market was arrived at after data triangulation from different approaches, including revenue share analysis, demand side analysis, and through secondary research. After the completion of each approach, the weighted average of the three approaches was taken on the basis of the level of assumptions used in each approach.
What were some of the companies that were approached to validate the study?
To validate our final data findings and assumptions considered for the study, we approached primaries from both supply and demand side of this market. Some of the top companies approached from the supply side included W.L Gore & Associates, Sanofi Genzyme, Biomup, amongst others. On demand side, various surgeons across different surgical areas were approached to understand the market dynamics. Additionally, independent consultants were also approached to validate the final market numbers.
Name some of the industry trends affecting the adhesion barrier market?
With the increasing number of minimally invasive surgeries, there is a growing demand for advanced biosurgical products. Minimally invasive surgeries, such as laparoscopic procedures, have been associated with minimum adhesions. The traditional forms of adhesion barriers, such as films, are not suitable for such surgeries, as they require larger incisions in order to be inserted. Hence, adhesion barrier gels are being researched for laparoscopic surgeries.
How is COVID-19 affectingthe dynamics of the adhesion barrier market?
Medical products such as adhesion barriers, which are considered as a part of the biosurgery field, are expected to show a small decline in revenues in the years 2020 and 2021 due to the pandemic. Additionally, the lockdown measures imposed globally have disrupted the supply of raw materials in order to manufacture these products. Another factor that has impacted the market is the slight delay in clinical trials assessments, which could further delay the launch of newer products in the market.
However, these factors have impacted the market only on a short-term basis. Post the COVID-19 scenario, awareness on the use of adhesion barrier products to avoid adhesion-related complications (such as infertility) will continue to aid in the increase in the adoption of such products during the forecast period .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 28)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 MARKET INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 33)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION
FIGURE 7 SUPPLY-SIDE ANALYSIS OF THE ADHESION BARRIERS MARKET
FIGURE 8 IMPACT OF COVID-19 ON THE GROWTH RATE (20192021)
2.2.1 TOP-DOWN APPROACH FOR SUBSEGMENT-LEVEL MARKETS
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. - 46)
FIGURE 10 ADHESION BARRIERS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 11 SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 12 ADHESION BARRIERS MARKET, BY FORMULATION, 2020 VS. 2025 (USD MILLION)
FIGURE 13 ADHESION BARRIERS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF THE ADHESION BARRIERS MARKET
4 PREMIUM INSIGHTS (Page No. - 50)
4.1 ADHESION BARRIERS MARKET OVERVIEW
FIGURE 15 INCREASING VOLUME OF SURGERIES AND GROWING AWARENESS OF ADHESION BARRIER PRODUCTS ARE DRIVING MARKET GROWTH
4.2 ASIA PACIFIC: ADHESION BARRIERS MARKET, BY PRODUCT AND COUNTRY (2019)
FIGURE 16 SYNTHETIC BARRIERS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC ADHESION BARRIERS MARKET IN 2019
4.3 ADHESION BARRIERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 CHINA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 52
4.4 REGIONAL MIX: ADHESION BARRIERS MARKET (2020−2025)
FIGURE 18 NORTH AMERICA WILL CONTINUE TO DOMINATE THE ADHESION BARRIERS MARKET IN 2025
4.5 ADHESION BARRIERS MARKET: DEVELOPING VS. DEVELOPED MARKETS
FIGURE 19 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 54)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Rising geriatric population
FIGURE 20 GROWTH IN THE GERIATRIC POPULATION, BY REGION, 19802050
TABLE 2 LIST OF COMMON SPECIALTIES AND PROCEDURES IN OLDER ADULTS
5.2.1.2 Increase in the volume of surgeries and sports-related injuries
TABLE 3 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGICAL PROCEDURES PERFORMED (2010 VS. 2020)
5.2.1.3 Increasing awareness about the medical implications of adhesions
5.2.2 RESTRAINTS
5.2.2.1 Reluctance of surgeons to use adhesion barriers
5.2.2.2 Product recalls
5.2.3 OPPORTUNITIES
5.2.3.1 Untapped emerging markets
5.2.4 CHALLENGES
5.2.4.1 Stringent regulations resulting in limited technological innovations
5.3 CONNECTED AND ADJACENT MARKETS
TABLE 4 ADJACENT AND RELATED MARKETS TO THE ADHESION BARRIERS MARKET
6 INDUSTRY INSIGHTS (Page No. - 60)
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 RISING FOCUS ON GEL-FORM ADHESION BARRIERS FOR SURGERIES
TABLE 5 AVERAGE ADHESION FORMATION RATE IN LAPAROSCOPIC SURGERIES
6.3 STRATEGIC BENCHMARKING
TABLE 6 PRODUCT PORTFOLIO ANALYSIS: NATURAL VS. SYNTHETIC ADHESION BARRIERS
TABLE 7 PRODUCT PORTFOLIO ANALYSIS: FILM VS. LIQUID VS. GEL-BASED ADHESION BARRIERS
6.4 CLINICAL TRIAL ASSESSMENT
TABLE 8 ADHESION BARRIER PRODUCTS CURRENTLY UNDER CLINICAL TRIALS
FIGURE 21 ADHESION BARRIER PRODUCT ASSESSMENT, BY APPLICATION AREA, FORMULATION, TYPE, AND LOCATION OF TRIAL (STUDY START PERIOD2017 ONWARD)
6.5 PARENT MARKET ANALYSIS
FIGURE 22 BIOSURGERY MARKET SNAPSHOT
6.6 COVID-19 IMPACT ON THE ADHESION BARRIERS MARKET
FIGURE 23 IMPACT OF COVID-19 ON THE ADHESION BARRIERS MARKET
FIGURE 24 DECLINE IN SALES OF BIOSURGERY DEVICES VS. ALL MEDICAL DEVICES
6.7 PORTER'S FIVE FORCES ANALYSIS
FIGURE 25 PORTER'S FIVE FORCES ANALYSIS
TABLE 9 PORTER'S FIVE FORCES ANALYSIS
6.7.1 THREAT OF NEW ENTRANTS
6.7.2 THREAT OF SUBSTITUTES
6.7.3 BARGAINING POWER OF SUPPLIERS
6.7.4 BARGAINING POWER OF BUYERS
6.7.5 INTENSITY OF COMPETITIVE RIVALRY
7 ADHESION BARRIERS MARKET, BY PRODUCT (Page No. - 71)
7.1 INTRODUCTION
TABLE 10 ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
7.2 SYNTHETIC ADHESION BARRIERS
TABLE 11 MAJOR BRANDS OF SYNTHETIC ADHESION BARRIERS
TABLE 12 SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 13 SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY, 20182025 (USD MILLION)
7.2.1 HYALURONIC ACID
7.2.1.1 Preference for hyaluronic acid is high among surgeons owing to its biocompatibility & bioresorbable properties
TABLE 14 HYALURONIC ACID-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 20182025 (USD MILLION)
7.2.2 REGENERATED CELLULOSE
7.2.2.1 Regenerated cellulose is used in gynecological surgeries
TABLE 15 REGENERATED CELLULOSE-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 20182025 (USD MILLION)
7.2.3 POLYETHYLENE GLYCOL
7.2.3.1 PEG is commonly used in abdominal and peritoneal surgeries
TABLE 16 POLYETHYLENE GLYCOL-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 20182025 (USD MILLION)
7.2.4 OTHER SYNTHETIC ADHESION BARRIERS
TABLE 17 OTHER SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY, 20182025 (USD MILLION)
7.3 NATURAL ADHESION BARRIERS
TABLE 18 LIST OF NATURAL ADHESION BARRIERS AVAILABLE IN THE MARKET
TABLE 19 NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 20 NATURAL ADHESION BARRIERS MARKET, BY COUNTRY, 20182025 (USD MILLION)
7.3.1 COLLAGEN & PROTEIN
7.3.1.1 Collagen & protein accounted for the largest share of the natural adhesion barriers market
TABLE 21 COLLAGEN & PROTEIN-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 20182025 (USD MILLION)
7.3.2 FIBRIN
7.3.2.1 Limited clinical evidence restraining the uptake of these natural adhesion barriers
TABLE 22 FIBRIN-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 20182025 (USD MILLION)
8 ADHESION BARRIERS MARKET, BY FORMULATION (Page No. - 82)
8.1 INTRODUCTION
TABLE 23 ADOPTION OF DIFFERENT ADHESION BARRIER FORMULATIONS IN SURGERIES
TABLE 24 ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
8.2 FILM FORMULATIONS
8.2.1 FILM FORMULATIONS ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET
TABLE 25 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIER FILMS
TABLE 26 FILM-FORM ADHESION BARRIERS MARKET, BY COUNTRY, 20182025 (USD MILLION)
8.3 LIQUID FORMULATIONS
8.3.1 LIQUID FORMULATIONS ARE WIDELY USED IN GYNECOLOGICAL, PELVIC, AND ABDOMINAL SURGERIES
TABLE 27 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIER LIQUIDS
TABLE 28 LIQUID-FORM ADHESION BARRIERS MARKET, BY COUNTRY, 20182025 (USD MILLION)
8.4 GEL FORMULATIONS
8.4.1 PREFERENCE FOR GEL-BASED FORMULATIONS IS GROWING AMONG END USERS
TABLE 29 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIER GELS
TABLE 30 GEL-FORM ADHESION BARRIERS MARKET, BY COUNTRY, 20182025 (USD MILLION)
9 ADHESION BARRIERS MARKET, BY APPLICATION (Page No. - 89)
9.1 INTRODUCTION
TABLE 31 ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
9.2 GYNECOLOGICAL SURGERIES
9.2.1 RISING INCIDENCE OF PELVIC AND UTERINE CANCER TO DRIVE THE DEMAND FOR ADHESION BARRIERS IN GYNECOLOGICAL SURGERIES
TABLE 32 PERCENT PREVALENCE OF INTRAUTERINE ADHESIONS ACROSS DIFFERENT GYNECOLOGICAL PROCEDURES
TABLE 33 COUNTRIES WITH THE HIGHEST C-SECTION RATE (2017)
TABLE 34 ADHESION BARRIERS MARKET FOR GYNECOLOGICAL SURGERIES, BY COUNTRY, 20182025 (USD MILLION)
9.3 GENERAL/ABDOMINAL SURGERIES
9.3.1 ADHESIONS ARE A COMMON COMPLICATION AND OCCUR IN 5560% OF ALL ABDOMINAL SURGERIES
TABLE 35 ADHESION BARRIERS MARKET FOR GENERAL/ABDOMINAL SURGERIES, BY COUNTRY, 20182025 (USD MILLION)
9.4 CARDIOVASCULAR SURGERIES
9.4.1 ADHESION BARRIERS ARE USED TO PREVENT POSTOPERATIVE COMPLICATIONS IN CARDIOVASCULAR SURGERIES
TABLE 36 LIST OF SOME COMMERCIALLY AVAILABLE ADHESION BARRIERS FOR CARDIOVASCULAR SURGICAL APPLICATIONS
TABLE 37 ADHESION BARRIERS MARKET FOR CARDIOVASCULAR SURGERIES, BY COUNTRY, 20182025 (USD MILLION)
9.5 ORTHOPEDIC SURGERIES
9.5.1 GROWING NUMBER OF SPORTS-RELATED INJURIES TO DRIVE THE DEMAND FOR ADHESION BARRIERS IN ORTHOPEDIC SURGERIES
TABLE 38 ADHESION BARRIERS MARKET FOR ORTHOPEDIC SURGERIES, BY COUNTRY, 20182025 (USD MILLION)
9.6 NEUROLOGICAL SURGERIES
9.6.1 GEL FORMULATIONS ARE THE MOST WIDELY USED ADHESION BARRIERS IN NEUROLOGICAL SURGERIES
TABLE 39 ADHESION BARRIERS MARKET FOR NEUROLOGICAL SURGERIES, BY COUNTRY, 20182025 (USD MILLION)
9.7 RECONSTRUCTIVE SURGERIES
9.7.1 HEALTH INSURANCE POLICIES FOR COSMETIC SURGERY PROCEDURES TO AID IN THE INCREASED USE OF ADHESION BARRIERS
TABLE 40 ADHESION BARRIERS MARKET FOR RECONSTRUCTIVE SURGERIES, BY COUNTRY, 20182025 (USD MILLION)
9.8 UROLOGICAL SURGERIES
9.8.1 HIGH INCIDENCE OF POSTOPERATIVE ADHESION FORMATION AFTER OPEN UROLOGICAL SURGERIES IN MORE THAN HALF OF THE TOTAL CASES
TABLE 41 ADHESION BARRIERS MARKET FOR UROLOGICAL SURGERIES, BY COUNTRY, 20182025 (USD MILLION)
9.9 OTHER SURGERIES
TABLE 42 ADHESION BARRIERS MARKET FOR OTHER SURGERIES, BY COUNTRY, 20182025 (USD MILLION)
10 ADHESION BARRIERS MARKET, BY REGION (Page No. - 100)
10.1 INTRODUCTION
TABLE 43 ADHESION BARRIERS MARKET, BY REGION, 20182025 (USD MILLION)
10.2 REGULATORY ANALYSIS
TABLE 44 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING MEDICAL DEVICES
TABLE 45 STRINGENCY OF REGULATIONS FOR ADHESION BARRIERS, BY COUNTRY
10.2.1 NORTH AMERICA
10.2.1.1 US
10.2.1.2 Canada
10.2.2 EUROPE
10.2.3 APAC
10.2.3.1 Japan
10.2.3.2 China
10.2.3.3 India
10.3 NORTH AMERICA
TABLE 46 US: ARTHROPLASTY PROCEDURAL VOLUME, BY YEAR (N = 1,525,435)
TABLE 47 NORTH AMERICA: HEALTHCARE EXPENDITURE, BY COUNTRY (USD BILLION)
FIGURE 26 NORTH AMERICA: ADHESION BARRIERS MARKET SNAPSHOT
TABLE 48 NORTH AMERICA: ADHESION BARRIERS MARKET, BY COUNTRY, 20182025 (USD MILLION)
TABLE 49 NORTH AMERICA: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 50 NORTH AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 51 NORTH AMERICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 52 NORTH AMERICA: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 53 NORTH AMERICA: ADHESION BARRIERS MARKET, BY APPLICATION, 0182025 (USD MILLION)
10.3.1 US
10.3.1.1 The US dominated the global market in 2019
FIGURE 27 POPULATION AGED 65 YEARS AND ABOVE IN THE US (20142060)
TABLE 54 US: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET
TABLE 55 US: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 56 US: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 57 US: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 58 US: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 59 US: ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
10.3.2 CANADA
10.3.2.1 Increasing Caesarean deliveries to drive the demand for adhesion barriers
TABLE 60 CANADA: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET
TABLE 61 CANADA: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 62 CANADA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 63 CANADA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 64 CANADA: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 65 CANADA: ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
10.4 EUROPE
TABLE 66 EUROPEAN COUNTRIES WITH THE HIGHEST C-SECTION RATE (2017)
TABLE 67 EUROPE: ADHESION BARRIERS MARKET, BY COUNTRY, 20182025 (USD MILLION)
TABLE 68 EUROPE: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 69 EUROPE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 70 EUROPE: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 71 EUROPE: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 72 EUROPE: ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
10.4.1 GERMANY
10.4.1.1 Germany accounted for the largest share of the European market in 2019
TABLE 73 GERMANY: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET
TABLE 74 GERMANY: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 75 GERMANY: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 76 GERMANY: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 77 GERMANY: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 78 GERMANY: ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
10.4.2 FRANCE
10.4.2.1 Rising number of advanced orthopedic surgeries to support market growth
TABLE 79 FRANCE: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET
TABLE 80 FRANCE: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 81 FRANCE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 82 FRANCE: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 83 FRANCE: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 84 FRANCE: ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
10.4.3 UK
10.4.3.1 UK has witnessed a rise in the number of cardiovascular, gynecological, and orthopedic surgeries
TABLE 85 UK: PERCENTAGE SHARE OF AGING POPULATION (20182036)
TABLE 86 UK: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET
TABLE 87 UK: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 88 UK: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 89 UK: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 90 UK: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 91 UK: ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
10.4.4 ITALY
10.4.4.1 Rising geriatric population and increasing prevalence of chronic diseases to drive market growth
TABLE 92 ITALY: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET
TABLE 93 ITALY: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 94 ITALY: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 95 ITALY: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 96 ITALY: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 97 ITALY: ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
10.4.5 SPAIN
10.4.5.1 High cost of surgical procedures in Spain to challenge the adoption of adhesion barriers
TABLE 98 SPAIN: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET
TABLE 99 SPAIN: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 100 SPAIN: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 101 SPAIN: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 102 SPAIN: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 103 SPAIN: ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
10.4.6 REST OF EUROPE
TABLE 104 ROE: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 105 ROE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 106 ROE: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 107 ROE: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 108 ROE: ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
10.5 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: ADHESION BARRIERS MARKET SNAPSHOT
TABLE 109 ASIA PACIFIC: ADHESION BARRIERS MARKET, BY COUNTRY, 20182025 (USD MILLION)
TABLE 110 ASIA PACIFIC: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 111 ASIA PACIFIC: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 112 ASIA PACIFIC: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 113 ASIA PACIFIC: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 114 ASIA PACIFIC: ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
10.5.1 JAPAN
10.5.1.1 Rising geriatric population to increase the number of surgical procedures performed in the country
TABLE 115 JAPAN: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET
TABLE 116 JAPAN: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 117 JAPAN: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 118 JAPAN: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 119 JAPAN: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 120 JAPAN: ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
10.5.2 CHINA
10.5.2.1 The top 3 regional adhesion barrier players account for 80% of the market in China
TABLE 121 CHINA: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET
TABLE 122 CHINA: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 123 CHINA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 124 CHINA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 125 CHINA: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 126 CHINA: ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
10.5.3 INDIA
10.5.3.1 High prices of adhesion barriers to hinder their adoption in the country
TABLE 127 INDIA: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET
TABLE 128 INDIA: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 129 INDIA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 130 INDIA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 131 INDIA: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 132 INDIA: ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
10.5.4 REST OF ASIA PACIFIC
TABLE 133 NEW ZEALAND: REGISTERED JOINT ARTHROPLASTIES CONDUCTED FROM 20102017
TABLE 134 ROAPAC: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 135 ROAPAC: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 136 ROAPAC: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 137 ROAPAC: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 138 ROAPAC: ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
10.6 LATIN AMERICA
TABLE 139 LATIN AMERICA: ADHESION BARRIERS MARKET, BY COUNTRY, 20182025 (USD MILLION)
TABLE 140 LATIN AMERICA: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 141 LATIN AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 142 LATIN AMERICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 143 LATIN AMERICA: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 144 LATIN AMERICA: ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
10.6.1 BRAZIL
10.6.1.1 Brazil is the largest market for adhesion barriers in Latin America
TABLE 145 BRAZIL: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET
TABLE 146 BRAZIL: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 147 BRAZIL: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 148 BRAZIL: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 149 BRAZIL: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 150 BRAZIL: ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
10.6.2 MEXICO
10.6.2.1 Rising burden of chronic diseases to drive market growth
TABLE 151 MEXICO: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET
TABLE 152 MEXICO: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 153 MEXICO: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 154 MEXICO: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 155 MEXICO: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 156 MEXICO: ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
10.6.3 REST OF LATIN AMERICA
TABLE 157 ROLATAM: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 158 ROLATAM: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 159 ROLATAM: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 160 ROLATAM: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 161 ROLATAM: ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
10.7 MIDDLE EAST
10.7.1 GYNECOLOGICAL AND GENERAL SURGERIES ACCOUNT FOR AROUND HALF OF THE TOTAL SURGERIES PERFORMED IN THE MIDDLE EAST
TABLE 162 MIDDLE EAST: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 163 MIDDLE EAST: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 164 MIDDLE EAST: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 165 MIDDLE EAST: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 166 MIDDLE EAST: ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
10.8 AFRICA
10.8.1 IMPLEMENTATION OF NATIONAL HEALTH INSURANCE PLANS TO REDUCE DISPARITIES IN CARE PROVIDED IN THE REGION
TABLE 167 AFRICA: ADHESION BARRIERS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 168 AFRICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 169 AFRICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 170 AFRICA: ADHESION BARRIERS MARKET, BY FORMULATION, 20182025 (USD MILLION)
TABLE 171 AFRICA: ADHESION BARRIERS MARKET, BY APPLICATION, 20182025 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 163)
11.1 INTRODUCTION
11.2 MARKET EVALUATION FRAMEWORK
FIGURE 29 MARKET EVALUATION FRAMEWORK: ACQUISITIONS WERE THE MOST ADOPTED STRATEGIES
11.3 GEOGRAPHIC REACH OF THE TOP PLAYERS (2019)
11.4 R&D EXPENDITURE OF THE TOP PLAYERS OPERATING IN THE ADHESION BARRIERS MARKET
FIGURE 30 R&D EXPENDITURE (USD MILLION): KEY PLAYERS IN THE MARKET
11.5 REVENUE SHARE ANALYSIS (20152019)
11.6 MARKET SHARE ANALYSIS (2019)
11.7 COMPANY EVALUATION MATRIX
11.7.1 STARS
11.7.2 EMERGING LEADERS
11.7.3 PERVASIVE PLAYERS
11.7.4 PARTICIPANTS
FIGURE 31 ADHESION BARRIERS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
11.8 COMPETITIVE SITUATION & TRENDS
11.8.1 ACQUISITIONS
11.8.2 PRODUCT LAUNCHES
11.8.3 REGULATORY APPROVALS
12 COMPANY PROFILES (Page No. - 170)
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 BAXTER INTERNATIONAL
FIGURE 32 BAXTER INTERNATIONAL: COMPANY SNAPSHOT (2019)
12.2 JOHNSON & JOHNSON (ETHICON, INC.)
FIGURE 33 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2019)
12.3 BECTON, DICKINSON AND COMPANY
FIGURE 34 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
12.4 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
FIGURE 35 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2019)
12.5 ANIKA THERAPEUTICS
FIGURE 36 ANIKA THERAPEUTICS: COMPANY SNAPSHOT (2019)
12.6 ATRIUM MEDICAL CORPORATION (A PART OF GETINGE GROUP)
FIGURE 37 GETINGE GROUP: COMPANY SNAPSHOT (2019)
12.7 TERUMO CORPORATION
FIGURE 38 TERUMO CORPORATION: COMPANY SNAPSHOT (2019)
12.8 FZIOMED
12.9 MAST BIOSURGERY
12.10 INNOCOLL HOLDINGS
12.11 BETATECH MEDICAL
12.12 CORMATRIX CARDIOVASCULAR, INC.
12.13 BIOSCOMPASS
12.14 W.L. GORE & ASSOCIATES
12.15 ALLOSOURCE, INC.
12.16 OTHER PLAYERS WITH ADHESION BARRIER PRODUCTS IN THE PIPELINE
12.16.1 XLYNK SURGICAL
12.16.2 LUNA INNOVATIONS
12.16.3 ACTAMAX SURGICAL MATERIAL, LLC
12.16.4 ARC MEDICAL DEVICES, INC.
12.16.5 CG BIO INC.
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 195)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
The study involved four major activities in estimating the size of the global adhesion barrier market. Exhaustive secondary research was done to collect information on the adoption of various products and formulations and their regional adoption trends. Industry experts further validated the data obtained through secondary research through primary research. Furthermore, the market size estimates and forecast provided in this study are derived through a mix of the bottom-up approach (country-level adoption of various adhesion barrier products) and top-down approach (assessment of adoption trends, by type of product, formulation, application and region). After that, market breakdown and data triangulation methods were used to estimate the market size of segments and subsegments.
Secondary Research
Various secondary sources such as the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), International Adhesions Society (IAS), American Orthopaedic Society for Sports Medicine (AOSSM), American Society for Reproductive Medicine (ASRM), American Surgical Association (ASA), International Society of Surgery (ISS), European Society of Surgery (ESS), European Society of Gynaecological Endoscopy (ESGE), Japan Surgical Society (JSS), annual reports/SEC filings as well as investor presentations and press releases of key players have been used to identify and collect information useful for the study of this market.
Primary Research
Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess the dynamics of this market. The primary sources from the supply side include CEOs, vice presidents, marketing and sales directors, business development managers, innovation and R&D directors, and key opinion leaders. Primary sources from the demand side include personnel from hospitals, ambulatory care centers, and researchers.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total market size for the adhesion barrier market was arrived at after data triangulation from two different approaches, as mentioned below.
Approach 1: Revenue Share Analysis
In this report, the global market size for the adhesion barriers marke was arrived at by calculating the revenues of individual companies from public sources and databases. Once the closest segment was identified, shares of the adhesion barrier products of leading players were gathered from secondary sources to the extent available. In certain cases, the shares of the adhesion barrier products have been ascertained after a detailed analysis of various parameters, including product portfolio, market positioning, selling price, and geographic reach and strength . Once arrived at these numbers, the Individual shares or revenue estimates were validated through expert interviews
Approach 2: Demand Side Analysis
In the case of demand-side analysis, the total number of surgeons adopting adhesion barrier products was studied using secondary and primary research. All the responses were collated to derive a probabilistic estimate of the market size based on the total number of barriers used per surgery type per year.
Data Triangulation
After arriving at the overall adhesion barrier market sizeusing the market size estimation processes as explained abovethe market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Report Objectives
- To define, describe, and forecast the global adhesion barrier market on the basis of product, formulation, application, and region.
- To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the adhesion barrier market with respect to six main regions (along with countries), namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global adhesion barrier market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, product launches, regulatory approvals, and R&D activities of the leading players in the global adhesion barrier market
Target Audience:
- Adhesion barrier manufacturers
- Medical device manufacturers
- Distributors and suppliers of medical implants
- Research institutes and academic centers
- Contract research organizations (CROs)
- Government associations
- Market research and consulting firms
- Venture capitalists and investors
Available customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the Rest of Europe adhesion barriers market into the Netherlands, Belgium, Switzerland, and others
- Further breakdown of the Rest of Asia Pacific adhesion barriers market into Australia, South Korea, New Zealand, and others
Company Information
- Detailed analysis and profiling of additional market players (Up to 5 players)
Growth opportunities and latent adjacency in Adhesion Barrier Market